MMP-3, also known as stromelysin-1, catalyzes the degradation of several substrates, including cartilage proteoglycan, collagen types II, IV, IX, and XI, laminin, and fibronectin, and is closely related to osteoarthritis severity [22]. Here, FN1 is linked to osteoarthritis.